Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
ITGR · NYSE · United States · Electromedical & Electrotherapeutic Apparatus
In shortInteger Holdings Corp is profitable, generates cash and carries moderate debt, with revenue growing (+8.0% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 11.9% | 56/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 5.5% | 42/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 6.1% | 31/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 6.2% | 41/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 3.32× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.68× | 73/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 3.32× | 19/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 5.12× | 34/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 3.52 | 62/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 5.7% | 43/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.02× | 90/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 3.7% | 98/100 |
| Operating margin volatility | 1.5% | 96/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 11.7% | 81/100 |
|---|---|---|
| EPS growth, 3-year average | 13.2% | 91/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 1,221 | 1,331 | 1,556 | 1,717 | 1,854 |
| Cost of revenue | 884 | 986 | 1,146 | 1,258 | 1,353 |
| Gross profit | 337 | 346 | 410 | 459 | 500 |
| Research & development | 52 | 60 | 62 | 53 | 49 |
| Selling, general & admin | 141 | 158 | 173 | 185 | 212 |
| Operating income | 136 | 113 | 163 | 208 | 221 |
| Interest expense | 32 | 39 | 53 | 56 | 43 |
| Pre-tax income | 101 | 69 | 105 | 148 | 125 |
| Income tax | 8 | 8.9 | 16 | 27 | 23 |
| Net income | 97 | 66 | 91 | 120 | 103 |
| Diluted EPS | $2.91 | $1.99 | $2.69 | $3.36 | $2.89 |
| Diluted shares (millions) | 33 | 33 | 34 | 36 | 36 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
3.52 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jul 3, 2026 · Data updated Aug 4, 2026